home / stock / lmdx / lmdx news


LMDX News and Press, LumiraDx Limited From 05/19/22

Stock Information

Company Name: LumiraDx Limited
Stock Symbol: LMDX
Market: NASDAQ

Menu

LMDX LMDX Quote LMDX Short LMDX News LMDX Articles LMDX Message Board
Get LMDX Alerts

News, Short Squeeze, Breakout and More Instantly...

LMDX - LumiraDx Five-Minute SARS-CoV-2 Ag Ultra Test Achieves CE Marking

LumiraDx Five-Minute SARS-CoV-2 Ag Ultra Test Achieves CE Marking PR Newswire Results in just 5 minutes from sample application, aids in fast clinical decision-making at point of care (POC), helping to inform treatment decisions and prevent the further spread of infect...

LMDX - LumiraDx's (LMDX) CEO Ron Zwanziger On Q1 2022 Results - Earnings Call Transcript

LumiraDx Ltd (LMDX) Q1 2022 Earnings Conference Call May 11, 2022 4:30 PM ET Company Participants Colleen McMillen – Vice President-Communications Ron Zwanziger – Chairman and Chief Executive Officer Dorian LeBlanc – Chief Financial Officer Pooja Pathak – Chief Pro...

LMDX - LumiraDx Non-GAAP EPS of -$0.13, revenue of $126.4M beats by $13.04M

LumiraDx press release (NASDAQ:LMDX): Q1 Non-GAAP EPS of -$0.13. Revenue of $126.4M (+18.2% Y/Y) beats by $13.04M. Cash balance at March 31 was $166.0 million. For further details see: LumiraDx Non-GAAP EPS of -$0.13, revenue of $126.4M beats by $13.04M

LMDX - LumiraDx Reports First Quarter 2022 Results

LumiraDx Reports First Quarter 2022 Results PR Newswire Strong Growth in Instruments Delivered to Customers and Continued Innovation on our Platform LONDON , May 11, 2022 /PRNewswire/ -- LumiraDx Limited (Nasdaq: LMDX), a next-generation point of ...

LMDX - LumiraDx to Announce First Quarter Financial Results and Host Quarterly Conference Call on May 11

LumiraDx to Announce First Quarter Financial Results and Host Quarterly Conference Call on May 11 PR Newswire LONDON , April 29, 2022 /PRNewswire/ -- LumiraDx Limited  (Nasdaq: LMDX), a next-generation point of care (POC) diagnostics company, announc...

LMDX - LumiraDx at a post-IPO low on expiry of lockup period - Evercore ISI

The shares of the diagnostic company LumiraDx (LMDX -22.7%) have recorded the biggest intraday loss Monday on above-average volume in a move Evercore ISI analyst Vijay Kumar attributed to the expiration of a six-month lock-up period. Compared to the 65-average of ~33.8K, about 586.6K company ...

LMDX - AMC, VIEW and COE among mid-day movers

Gainers: DatChat (DATS) +82%. Hycroft Mining Holding Corporation (HYMC) +66%. Plantronics (POLY) +50%. Kaixin Auto (KXIN) +31%. AMC Entertainment Holdings (AMC) +25%. TC Biopharm (TCBP) +23%. Creative Medical Technology (CELZ) +21%. Immunome (IMNM) +21%. Chi...

LMDX - Good Stocks To Buy Right Now? 4 Health Care Stocks For Your List

4 Health Care Stocks For Your Mid-March Watchlist With the stock market continuing to tread water, many investors are looking for safer investments to fend off the volatility. While we may not be in a bear market as far as the main indices are concerned, it’s never a bad ...

LMDX - LumiraDx Limited (LMDX) CEO Ron Zwanziger On Q4 2021 Results - Earnings Call Transcript

LumiraDx Limited (LMDX) Q4 2021 Earnings Conference Call March 10, 2022, 8:00 AM ET Company Participants Ron Zwanziger – Chief Executive Officer Dorian LeBlanc – Chief Financial Officer Colleen McMillen – Vice President of Communications Pooja Pathak – Chief Produc...

LMDX - LumiraDx Non-GAAP EPS of -$0.08, revenue of $118.25M misses by $0.63M

LumiraDx press release (NASDAQ:LMDX): Q4 Non-GAAP EPS of -$0.08. Revenue of $118.25M (+5.3% Y/Y) misses by $0.63M. For further details see: LumiraDx Non-GAAP EPS of -$0.08, revenue of $118.25M misses by $0.63M

Previous 10 Next 10